BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

836 related articles for article (PubMed ID: 21557766)

  • 1. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
    Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
    FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of MiR-93 expression reduces cell proliferation and clonogenicity of HepG2 cells.
    Xu D; He XX; Chang Y; Sun SZ; Xu CR; Lin JS
    Hepatogastroenterology; 2012; 59(120):2367-73. PubMed ID: 22773266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
    Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
    Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway.
    Xu J; Zhu X; Wu L; Yang R; Yang Z; Wang Q; Wu F
    Liver Int; 2012 May; 32(5):752-60. PubMed ID: 22276989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma.
    Jia XQ; Cheng HQ; Qian X; Bian CX; Shi ZM; Zhang JP; Jiang BH; Feng ZQ
    Cell Biochem Biophys; 2012 Jan; 62(1):237-44. PubMed ID: 21847633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.
    Xie Q; Chen X; Lu F; Zhang T; Hao M; Wang Y; Zhao J; McCrae MA; Zhuang H
    Cancer; 2012 May; 118(9):2431-42. PubMed ID: 21989846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [miR-143 inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of TLR2 expression].
    Wang Y; Lu Z; Li Y; Ji D; Zhang P; Liu Q; Yao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1076-9. PubMed ID: 25270212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of miR-650 is correlated with down-regulation of ING4 and progression of hepatocellular carcinoma.
    Zeng ZL; Li FJ; Gao F; Sun DS; Yao L
    J Surg Oncol; 2013 Feb; 107(2):105-10. PubMed ID: 22767438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
    Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
    Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of XPO4 is associated with poor prognosis in hepatocellular carcinoma.
    Liang XT; Pan K; Chen MS; Li JJ; Wang H; Zhao JJ; Sun JC; Chen YB; Ma HQ; Wang QJ; Xia JC
    J Gastroenterol Hepatol; 2011 Mar; 26(3):544-9. PubMed ID: 21332550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma.
    Xiang ZL; Zeng ZC; Fan J; Tang ZY; Zeng HY; Gao DM
    Clin Cancer Res; 2011 Aug; 17(16):5463-72. PubMed ID: 21712445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
    Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
    J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis.
    Wang J; Li J; Wang X; Zheng C; Ma W
    Biochem Biophys Res Commun; 2013 Sep; 439(1):47-53. PubMed ID: 23962428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma.
    Zhang Y; Guo X; Xiong L; Kong X; Xu Y; Liu C; Zou L; Li Z; Zhao J; Lin N
    FEBS Lett; 2012 Dec; 586(24):4362-70. PubMed ID: 23178713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
    Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K
    J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion.
    Li Q; Wang G; Shan JL; Yang ZX; Wang HZ; Feng J; Zhen JJ; Chen C; Zhang ZM; Xu W; Luo XZ; Wang D
    J Gastroenterol Hepatol; 2010 Jan; 25(1):164-71. PubMed ID: 19793168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes].
    Fu XY; Tan DM; Hou ZH; Hu ZL; Liu GZ; Ouyang Y; Liu F
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):598-604. PubMed ID: 23207154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma.
    Hamaguchi T; Iizuka N; Tsunedomi R; Hamamoto Y; Miyamoto T; Iida M; Tokuhisa Y; Sakamoto K; Takashima M; Tamesa T; Oka M
    Int J Oncol; 2008 Oct; 33(4):725-31. PubMed ID: 18813785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3.
    Huang N; Lin J; Ruan J; Su N; Qing R; Liu F; He B; Lv C; Zheng D; Luo R
    FEBS Lett; 2012 Mar; 586(6):884-91. PubMed ID: 22449976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.